Maharashtra Governor Kateekal Sankaranarayanan is the chief at Pharmaleaders’s 5th Annual Pharmaceutical Leadership Annual Summit & Business Leadership Awards 2012

Maharashtra Governor  Kateekal Sankaranarayanan is the chief at Pharmaleaders’s 5^th Annual Pharmaceutical Leadership Annual Summit & Business Leadership  Awards 2012

His Excellency Kateekal Sankaranarayanan will give away Awards to the Shining Stars of Indian Healthcare Industry & Address to the Industry Gatherings.

Mumbai, Maharashtra,12^th Sept 2012 : Pharmaleaders’s much awaited Annual Leadership Event 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 ( www.asiapharmaleaders.com ) will be graced & inaugurated by Maharashtra Governor Kateekal Sankaranarayanan to be held in Mumbai on Friday, the 21^st September 2012  at Hotel Hilton Mumbai International Airport, Mumbai India. Organised by Pharmaleaders ( www.pharmaleaders.co.in ) in association with Pharmexcil, India Brand Equity Foundation (IBEF), Breakfast News TV ( www.breakfastnews.tv ) with the support of Ministry of Commerce & Industries, Government of India & several other leading trade bodies, Pharma Industry organizations. The widely awaited much acclaimed  event of Asia’s Biggest Leadership Event entering in its 5^th glorious years, Pharmaceutical Leadership Summit & Business Leadership Awards 2012 under the theme “Brand India, Beyond Generics, Leading with Resilience: Coming Back from Challenge and Heading Towards Super-power Status” will be attended by more than top 200 owners of the  Indian Pharmaceutical Industry, CEO’s & veteran think-tanks including leading medical practitioners, Pharma Academia, consultants, policy makers besides attendance from overseas companies from middle east, Europe & Gulf.

Speaking on the announcement of His Excellency, Maharashtra Governor  Kateekal Sankaranarayanan’s participation as Chief Guest of the Pharmaceutical Leadership Summit 2012, Satya Brahma, Editor-In-Chief of Pharmaleaders & Chairman of the organizing Committee of the 5^th Annual Pharmaceutical Leadership Summit said “ The consent of the Maharashtra Governor  K .Sankaranarayanan’s presence as Chief Guest at the much awaited Asia’s largest get together plattform is indeed  big news considering the magnitude of the Event & no other dignitaries could have added such grace 7 prestige to the event other than His Excellency. We are excited & thrilled as the highest constitutional post of the Maharashtra Government will be the chief Guest to give away the awards & address to the who’s & Who’s of the Indian Healthcare Industry. “Governor Shankaranarayan has glorious track record as an able administrator & hails from Kerala & held several key posts including the Finance Minister in Kerla in the past & is a popular mass leader”, said Satya.

5^th Annual Pharmaceutical Leadership Summit 2012 will also release an exclusive booklet on Brand India Pharma by India Brand Equity Foundation ( IBEF) & Pharmexcil. A detailed & exclusive Whitepaper on “The Future of Clinical Trial Services (Phase I to IV) in India – The Road Ahead” prepared by Ms Nidhi Saxena, Founder, President & CEO,. Karmic Lifesciences will also be released.

The Summit will witness more than top 20  Asia Pharmaleaders debating on the complex issues on how the indian healthcare industry is charting out its map in the global landscape. Those who will debate & Address at the Summit are powerful faces & voices of the Indian Pharmaceutical & Biotech Industry such as Dr Mahesh Burande, Hon Director, Institute of Pharmaceutical Education and Research (IPER) on Challenges and Opportunities for Indian Pharma Industry to become Pharma Superpower in 2020, Mr. Kewal Handa, Ex Managing Director, Pfizer Ltd. & Wyeth Ltd on Branded Formulations VS Branded Generics, 2012 Pharmaceutical Diversification Trends, Making of Dr Batras Brand . Indian Experience VS Global Challenges by Dr Mukesh Batra.Founder Chairman, Dr Batra’s Positive Clinic, Are We Ready For A Mechanical Artificial Heart for Indian Patients by Dr Mukesh Hariawala, Renowned Cardiac Surgeon & Healthcare Economist, Harvard Medical School Affiliated Hospitals, Boston, USA, Regulatory Challenges of Indian Pharmaceutical companies. A CEO’s Perspective by Dr. Shenaz Khaleeli Co- Founder & Technical Director, PharmaLeaf India Pvt Ltd, Delivering value in the Supply Chain by Ms Sue Arden, VP Life Sciences & Healthcare.  DP DHL, Singapore, Neutraceutical & OTC Sector,the European Market Challenge by François Licoppe, CEO,Eubage Laboratory, Belgium, Indian Pharma Industry ,Challenges & Key Issues in partnership, Alliances & Co-Marketing by Shivkumar Kunchithapatham, Managing Director,  Eisai Pharmaceuticals India Private Limited, Innovative Trends in Facial Aesthetics – Indian Challenges with Global Experiments by Dr. Shuba Dharmana, Cosmetic Dermatologist, Laser Specialist, Hair Transplant Surgeon by CEO Dr.Shuba Skin & Laser Clinic . Besides Dr Rajaram Samant, Founder Chairman, Akumentis Healthcare Ltd, S.V.Veerramani, CMD, Fourrts(India) Laboratories Pvt Ltd, Dr. B.R. Shetty, Founder,Managing Director & CEO, NMC Healthcare, Abu Dhabi, U.A.E, Dr Rashmi Shetty, Cosmetologist, and pioneer and leading expert for Non-Surgical Aesthetic Medicine,Dr Kannan Vishwanath, VC, MD, Aanjaneya Lifecare Ltd will be debating on a high powered panel discussion Brand India Pharma.

Maharashtra Governor Kateekal Sankaranarayanan  will give away the much awaited Pharmaleaders Business Leadership Awards 2012 in as many as 33 categories where presently Nominations are underway & votings for the Nominations to choose the Winner is going on in  more than 9 countries with a sample size of 5 Lakh 56 thousand & 674 voters spread across 21  states & 4 industry verticals in India via online, sms & physical interviews . Commenting on the Award Nominations, Jury Chairman Satya Brahma said “Past Award winners from this platform  have shown how companies can help boost sustainable growth and development, they can be a tremendous source of innovative and sustainable solutions, which help transform people’s lives for the better & these Awards will highlight the critical role of the private sector in stimulating sustainable economic growth and development. A detailed Analysis of career graph/History or notable achievement is looked at to get the final four names. Factors such as ,   Financial management, Decision making roles and business impact, Business ethics, Managing rapid growth,Innovation,adapting to change, Strategic partnerships, Leadership roles, Marketing strategies, Corporate philanthropy/contributions to society will be the key to win the prestigious Award Title in various categories.

The 5^th Annual Pharmaceutical Leadership Awards will be presented in a star-studded gala award evening on 21^st September in Mumbai & the Winners will be announced in the Evening at the Award Night.

Celebrity Doctors: After Cinema & Sports, Brand Ambassadors May Well Come Medical Veterans

Celebrity Doctors: After Cinema & Sports, Brand Ambassadors May Well Come Medical Veterans

Pharmaleaders Research reveal the rising interest of the Healthcare Sector’s aggressive campaign to rope Celebrity Doctors. Dr Mukesh Hariawala, Dr Shuba Dharmana, Dr Devi Shetty, Dr Naresh Trehan top the List.

Maharashtra, Mumbai, Friday 7^th September 2012 : In the run up to the 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 ( www.asiapharmaleaders.com ) organized by Pharmaleaders Group ( www.pharmaleaders.co.in ) in association with Pharmexcil, BSE India, IBEF & host of other trade bodies & pressure group in healthcare sector with the support of Ministry of Commerce & Industries in the commercial capital of India on 21^st September 2012 at Hotel Hilton, Mumbai, India, the  research & survey conducted by Breakfastnews TV (www.breakfastnew.tv )& Pharmaleaders Magazine bring out some startling results. We all know that in a country like India where Brand Loyalty largely stem from endorsements from Brand Icons largely from Bollywood, Sport stars mostly from Cricketing world. With the marketing becoming tougher & competative, many healthcare companies are revisiting their marketing plans & strategies in order to have a grip in the market. Indian Healthcare Market is largely dominated by endorsements from the doctors by the Medical Representatives in updating them on the benefits of the products. However, in OTC market, the scenario is different & huge money is spent on print & Electronic Advertisements & the big fish here are matinee idols & Sport stars.

India is a country where people love to live in dreams. They worship celebrities & build temples for them without knowing their real background. Celebrities may be cricket stars like Sachin Tendulkar, Mahindra Singh Dhoni or film stars like Amitabh Bachchan, Salman Khan, and Shah Rukh Khan etc. They are treated as God. Marketers use this very proposition so as to influence their target customers, maybe existing or potential ones. For this they rope in these celebrities and give them whopping amount of money. But the bigger issue is says Satya Brahma, Editor-In-Chief of Pharmaleaders “Is it good for pharmaceutical companies to pay celebrities to be spokespeople to raise awareness of medical conditions?, also Given the power of of celebrities to influence people, pharmaceutical companies have come out with a innovative & cost effective plans, that of roping Celebrity Doctors & Medical Wizards”. The Indian OTC pharmaceuticals market generated total revenues of $1.8 billion in 2010, representing a compound annual growth rate (CAGR) of 6.4% for the period spanning 2006-2010. -Vitamins and minerals sales proved the most lucrative for the Indian OTC pharmaceuticals market in 2010, generating total revenues of $471.2 million, equivalent to 25.8% of the market's overall value. -The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.6% for the five-year period 2010-2015, which is expected to lead the market to a value of $2.3 billion by the end of 2015 said Satya.

The Indian pharmaceutical sector has come a long way, from being a small player in 1970, to becoming a prominent provider of healthcare products, meeting almost 95 per cent of the country‘s pharmaceutical needs today. Pharmaleaders Research reveals that the pharmaceutical industry in India has a unique and exciting opportunity to grow & prosper. India accounts for 8 % of global pharmaceutical production. It is the third largest in terms of volume and fourteenth in terms of value. Indian firms produce about 60000 generic brands across 60 therapeutic categories and 500 active pharmaceutical ingredients (APIs) approximately. India boasts an export of generic drugs worth US $11 billion and the generic drug market is predicted to grow at a CAGR of 17 per cent between 2010-11 and 2012-13.2 $5.5 bn in 2000 to US $ 25 bn in 2020.

Indian Pharma Majors such as Ranbaxy, Paras Pharma, Elder Pharmaceuticals, Mankind, Alkem labs, Nicholas Piramal, Abbott, Pfizer, GSK etc spend a huge money on Celebrity Branding. Ranbaxy reportedly paid huge amount for its star Brands Voilini & Revital to stars such as Salman Khan, Yuvraj Singh, Tisca Chopra & lately Sonali Bendre. Sources close to Pharmaleaders reveal that the endorsements give huge returns given Indian typical mindset & lack of wider knowledge. However lately, Pharma Companies balance sheet reflected more money to Celebrity Fees than sometimes a unit’s manufacturing cost.

To combat these challenges, Pharmaceutical & Medical Companies have started out looking at leading faces & credible voices in the medical practice whose knowledge on the product & endorsement appeal has a bigger impact than the Superstars said an Ad Agency roped in for finding star Doctors after giving a try in Sports & Cinema. “Given the uncertainty of Star Appeal when they run in controversies or out of form players result in negative results & moreover they have bigger problems, egos & status” said Tanya who heads a Mumbai based Ad Agency. She admitted that next ibn line will be the Doctors who will have the mass appeal & their fees will be lesser compared to bigger fees by the Stars. It is no surprising that more & more Pharma Companies are getting into OTC segment to reach out to masses & pocket a bigger share”.

With these objectives, to know the pulse of consumers, Pharmaleaders undertook a research to find out the reasons why Doctors are increasingly becoming the favorite for the Drug & FMCG Companies. How about celebrities being paid to promote specific OTC treatments? Is that OK? Do such celebrity spokespeople provide a good return on investment for pharmaceutical marketers?. These are the questions that come to mind. So this prompted Pharmaleaders Researchers to know the pulse of people.

Pharma leaders sample profiles included the demographic characteristics of the respondent consumers covered in the analysis. Demographic factors like age, education, occupation, income, family size have a direct influence on the product/ brand choice. To ascertain the views of both male and female consumers, almost equal numbers of respondents are selected for the study. On the basis of age, the respondents are classified into five categories viz. below 20 years, 21-30 years, 31-40 years, 41-50 years, and above 50 years. Around 39 percent respondents are in the age group of 21-30 years. Another 27 percent are in the age group of 31-40 years. Around 16 percent are in the age group of 41-50 years, followed by above 50 years (13 percent), and below 20 years (5 percent). It is observed that majority of respondents comprising 73 percent are either graduates or post graduates. The remaining 27 percent have below graduation educational background. It is also observed that private employees comprise 38 percent of sample followed by housewives (25 percent), and government employees (18 percent). The remaining are students, businessmen and professionals. It is found that 43 percent respondents are in the middle income group (Rs. 10,001 to 20,000/pm). At the same time, 31 percent belong to low income group (Below Rs. 10,000/ pm). The remaining 26 percent belong to high income category (above Rs. 20,000/pm). It is seen that around 63 percent respondents have 3-4 members in their families. Around 26 percent have more than 4 three members. Another 11 percent have two or less members. It is observed that 62 percent respondents spend below Rs 300/per month on a vitamin product. The remaining 38 percent respondents spend above Rs 200/- per month. This gives occupation wise, income wise, and lifecycle wise distribution of sample consumers of Pharmaceutical Over The Counter Products (OTC). The behavior of urban respondents towards OTC products in terms of influencing factors such as buying habits, and brand loyalty are also analyzed.

The Respondents who were asked to answer, given the choice, whom will they look at their choice to influence their buying habits, the list were endless with big medical names such as Dr Ramakant Panda, Dr Bhattacharya, Dr Sidharth Shah, Dr N.S.Laud etc. But close to the maximum choices who will have mass appeal & who topped the research are celebrity Indo-American Heart Surgeon Dr Mukesh Hariawala, Eminent cardiologists Dr Naresh Trehan & Devi Shetty. Dr Shuba Dharmana who is a Dermatologist appeared favorite for endorsing skin & wellness products. But the big question is will these Doctors risk attaching their names to a specific company or a Brand, that time can answer.

India Needs Doctors, Nurses, Health Insurance, PHU’s & Quality free Medicines- - Pharmaleaders-

India Needs Doctors, Nurses, Health Insurance, PHU’s & Quality free Medicines- - Pharmaleaders-

Industry Veterans Dr Mukesh Batra, Mr. Kewal Handa, Dr B.R Shetty, Dr Mukesh Hariawala,Dr Kannan Vishwanath, Shivkumar Kunchithapatham, Dr Rajaram Samant, Dr Rashmi Shetty, Dr Shuba Dharmana, François Licoppe, V.Veerramani, Dr Mahesh Burande to address

Maharashtra, Mumbai, 2^nd September 2012: India needs doctors, nurses and health insurance, Public Healthcare Units, Free Medicines for poor &  & moreover the brand India Pharma Image cant be realized unless & until a strong healthcare policy is in place & healthcare reforms to address the challenges of getting quality medicines at affordable price, feel the illustrious list of speakers who will gather to debate at historic & prestigious 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 ( www.asiapharmaleaders.com )( www.breakfastnews.tv ). Pharmaleaders, a Mumbai based healthcare media group (www.pharmaleaders.co.in ) in association with country’s biggest trade bodies & associations is debating the critical issues on 21^st September 2012 on a Theme “Brand India Pharma, Beyond Generics. Leading with Resilience: Coming Back from Challenge and Heading Towards Super-power Status”.

Ø  India has just seven doctors per 10,000 people, while China has 14 per 10,000

Ø  Less than 23 percent of Indians are covered by policies

Ø  95 percent of the population in China are  covered by some sort of insurance, India is nil

Ø  There are just Eleven  hospital beds per 10,000 people in India, compared with 41 per 10,000 in China.

Ø  Access to basic Medicine by the large chunk of Indian Population is still an issue.

Ø  Quality Medicines at Affordable Prices is still a slogan.

The Leadership Summit will witness the who’s & Who’s of Indian Healthcare Industry with 10 plenary sessions to cover the burning issues of the sector such as Challenges and Opportunities for Indian Pharma Industry to become Pharma Superpower in 2020 by  Dr Mahesh Burande, Hon Director,Institute of  Pharmaceutical Education and Research (IPER). Branded Formulations VS Branded Generics, 2012 Pharmaceutical Diversification Trends by  Kewal Handa, Ex Managing Director, Pfizer Ltd. & Wyeth Ltd, Making of Dr Batras Brand,  Indian Experience VS Global Challenges by Dr Mukesh Batra.Founder Chairman, Dr Batra’s Positive Clinic, Are We Ready For A “Mechanical Artificial Heart For Indian Patients by Dr Mukesh Hariawala, Cardiac Surgeon & Healthcare Economist, Harvard Medical School Affiliated Hospitals, Boston, USA. Regulatory Challenges of Indian Pharmaceutical companies. A CEO’s Perspective by Dr. Shenaz Khaleeli ,Co- Founder & Technical Director, PharmaLeaf India Pvt Ltd, Delivering value in the Supply Chain by Sue Arden, VP Life Sciences & Healthcare.  DP DHL, Singapore, Neutraceutical & OTC Sector: The European Market Challenge by François Licoppe, CEO,Eubage Laboratory, Belgium, Indian Pharma Industry : Challenges & Key Issues in partnership, Alliances & Co-Marketing by  Shivkumar Kunchithapatham, Managing Director,  Eisai Pharmaceuticals India Private Limited, Innovative Trends in Facial Aesthetics – Indian Challenges with Global Experiments by Dr. Shuba Dharmana Cosmetic Dermatologist, Laser Specialist, Hair Transplant Surgeon, CEO Dr.Shuba Skin & Laser Clinic. The Event will see a high powered panel discussion on Globalization of Indian Brands: Key Challenges & Opportunities by the Experts such as Mr. Kersi Tavadia, CIO, Bombay Stock Exchange Limited,.            Mr.Rakesh Bhargava, Chairman, Fresenius Kabi Oncology Ltd, Dr Shuba Dharmana, Dermatologist, Hair Transplant surgeon & Aesthetic & Laser, Dr Mahesh Burande, Hon.Director Institute of Pharmaceutical Education and Research & Consultant, Dr Rajaram Samant, Founder Chairman, Akumentis Healthcare Ltd, Mr S.V.Veerramani, CMD, Fourrts(India) Laboratories Pvt Ltd, Dr. B.R. Shetty, Founder,Managing Director & CEO, NMC Healthcare, Abu Dhabi, U.A.E, Dr Mukesh Batra, Chairman, Dr Batra's Positive Health,     Dr Rashmi Shetty, Cosmetologist, and pioneer and leading expert for Non-Surgical Aesthetic Medicine,  Dr Kannan Vishwanath, VC, MD, Aanjaneya Lifecare Ltd.

Speaking on the high panel speaker & battery of experts who will gather to speak at Pharmaleaders Annual Meet, Satya Brahma, Editor-In-Chief of Breakfast news ( www.breakfastnews.tv ( & Pharmaleaders said “Unlike Europe such as Canada & others, Healthcare is given a top priority & the reforms are on top of the Agenda & the respective Governments are concerned about it, In India Healthcare is  not delivered through a publicly funded health care system & lacks transparency & synergy of systems, poor policies arising out of a fractured mandate, Coalition  government at the Center are paralyzing Indian healthcare sector”. This Conglometer will address the core Issues added satya Brahma.

The Indian Pharma industry accounts for ~20% (volume terms) of the global generics industry. During the 11th plan period, the domestic pharma market grew at 14% CAGR and exports grew at 19% CAGR with anti infective, anti asthmatic and anti hypertensive being the major therapeutic categories. USA, Russia, Germany, Austria and UK are the top export destinations with USA alone accounting for almost 20% of total exports. Although the industry is fragmented, the large and medium sized pharma companies contribute to ~75% of the domestic sales and over 90% of exports. 

The overall pharmaceutical industry was pegged at Rs 1,000 billion (~USD 20 billion) with the domestic pharma industry at over Rs 600 billion (~USD 12 billion) in 2009-10. The bulk drugs contributed to about Rs 420 billion (USD 8.4 billion). The country has about 10,563 manufacturing units with about 300 large and medium units and remaining in the small scale and unorganized sector.   The Department of Pharma in its 12th plan aims to increase the size of the industry to USD 60 billion with exports contributing to over USD 25 billion. The contribution of bulk drugs is aimed at USD 28 billion (47% contribution). About USD 300 billion worth of patented drugs are expected to become generic by 2015 and this would a major driving factor for our exports. The Leadership Event will felicitate the shining stars of Indian Healthcare sector at 5^th Annual Pharmaceutical Leadership Awards 2012.

India Set To Select Business Leader of The Year Award 2012 at Pharmaceutical Leadership Awards 2012

India Set To Select Business Leader of The Year Award 2012 at Pharmaceutical Leadership Awards 2012

Dr Mukesh Batra, Dilip Sanghavi, Dr Krishna Ella & R.C.Juneja are in the race to the prestigious Pharmaleaders’s 5^th Annual Business Leadership Awards 2012

Mumbai, Maharashtra,Friday, 31^st August 2012 :  As Asia’s Biggest Leadership Event In Healthcare & Biotechnology Annual Event Is Coming Closer, The Battle For The Business Leader Of The Year Award 2012 goes deeper & intense as the nation is set to select the winner from the four finalists who made it to the Nomination at 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 ( www.asiapharmaleaders.com )in a nationwide voting currently underway. Organised by Asia’s Most Analytical Healthcare Bi-Monthly Pharmaleaders ( www.pharmaleaders.co.in ), The Award Title has four big players in the Indian Pharmaceutical & Healthcare Industry with a successful track record of establishing their respective businesses both in india & overseas with a huge branding.

In the race to the prestigious title are, Dilip Sanghavi, MD, Sun Pharmaceutical IndustriesLtd , Dr Krishna Ella, CMD, Bharat Biotech International Ltd Dr.  Mukesh Batra, Founder Chairman, Dr Batra’s.& R. C. Juneja, Managing Director, Mankind Pharma Ltd. Sun Pharma Chief Sanghavi runs india’s biggest pharmaceutical Empire called Sun Pharma while Dr Ella is a reputed veteran in  Botech Research with a scientific mindset. Padmashree Dr Mukesh Batra is India’s pioneer Homeopath Doctor who revolutionized india’s thinking towards the homeopathy & Mankind Pharma Chief Juneja is a Brand Icon who quickly catapulted to the top 10 by some aggressive marketing. Commenting on the competation, Satya Brahma, Editor-In-Chief of Breakfast News TV ( www.breaklfastnews.tv ) said “ It will be phenomenally difficult for the respondents who are asked to name only one out four big names. However, this competition is  bound to be competitive as the names have tremendous brand value”. Harvard trained, eminent Indian American iconic Heart Surgeon & Research Scientist Dr Mukesh Hariawala  who will deliver the keynote lecture on receipt of this year’s prestigious " India's Most Admired Surgeon  award said “ This category will have much to say, the way Indian healthcare landscape is progressing, while the voters will have their respective views on their personal choices to cast their vote, at the end of the day, they will have to choose one & this will be huge recognition said Dr Hariawala.    

Pharmaceutical Leadership  Awards have been presented since last one decade at a sold-out gala to over 500 industry executives and leading academic scientists from around the world. Each Award or Nomination are being screened by the Board Members of Pharma Leaders Group consisting of 12 Member Team & than further approved by Network 7 Media Group consisting of eminent members of the Healthcare Community. After through screening, the names of four Nominees emerge out & are thrown out to public by E-mail Voting, Than SMS Voting followed by the final verdict of the Jury Members. The Awards demonstrate how companies can, through their core business activities, help achieve excellence in innovations. The 2012 Award Nominations has been given explicitly to companies delivering inclusive business models which are sustainable, commercially-viable business initiatives that expand access for low-income people to goods and services, or improve their livelihoods by engagement in value chains as direct employees, suppliers or distributors, while also generating sales and profit growth. By bringing together examples of innovative, effective business practices, 5th Annual Pharmaceutical Leadership Awards will also provide leading businesses and entrepreneurs with a valuable platform for networking and sharing experiences, and promote best practices. This will encourage other businesses and governments to replicate and scale initiatives. An international judging panel made up of representatives of the organizing partners as well as non-governmental organizations, universities, business entities, and international institutions will determine this year’s winners. A knowledge-exchange workshop focussed on inclusive business will take place prior to the awards ceremony.

In 2011, the Awards received an unprecedented 172 nominations, representing a variety of business and commercial endeavors undertaken by business associations, non-governmental organizations and individual companies from more than 9 countries sample size of 5 Lakh 56 thousand & 674 voters spread across 21  states & 4 industry verticals via online, sms & physical interviews . “Past Award winners have shown how companies can help boost sustainable growth and development,” said Satya Brahma. “They can be a tremendous source of innovative and sustainable solutions, which help transform people’s lives for the better." These Awards will highlight the critical role of the private sector in stimulating sustainable economic growth and development.” A detailed Analysis of career graph/History or notable achievement is looked at to get the final four names. Such as ,Financial management, Decision making roles and business impact,Business ethics,Managing rapid growth,Innovation,Adapting to change,Strategic partnerships,          Leadership roles,Marketing strategies,Corporate philanthropy/contributions to society.

The Winner will be announced on Friday, 21^st September 2012 at Hotel Hilton Mumbai International Airport at the gala Award Night which will also have a International Summit on theme Brand India, Beyond Generics : Leading with Resilience: Coming Back from Challenge and Heading Towards Super-power Status.

Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar, & Microlab’s Ashok jain, to receive the coveted title at 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012

Pharma Professionals Of The Decade At 5^th Annual Pharmaceutical Leadership Awards To Recognize Shining Stars Of Indian Healthcare Industry

Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar, & Microlab’s Ashok jain, to receive the coveted title at 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012

Maharashtra, Mumbai, Friday, 17th August 2012: Indian Pharmaceutical & Biotech Industry over the years has evolved out in the global map as the leading destination & manufacturing hub for sourcing pharmaceutical API’s & Formulations. Indian Pharmaceutical Sector has the distinction of being one of the most preferred location for export of pharmaceutical products at affordable prices. Indian pharmaceutical industry is poised to grow at the rate of 18 per cent by the year 2016-17, the Parliament was informed today. "According to the Report of the Working Group on Drugs and Pharmaceuticals Industry for XII Five Year Plan, the projected rate of growth for Indian Pharmaceutical industry is envisaged as 18 per cent by 2016-17," Minister of State for Chemicals and Fertilizers Srikant Kumar Jena said in a written reply to Indian Parliament. The projected rate of growth of the industry in domestic market has been envisaged as 21 per cent and the projected growth rate in the international market has been envisaged as 16 per cent, he added. "The estimated value of business of the Pharmaceuticals Industry in 2008 was Rs 80,300 crore which reached to Rs 1,04,209 crore in March 2010," Jena said.

Undoubtedly, the robust growth of Indian Pharmaceutical Industry in India as well as in abroad would not have been possible without the visionary leadership & farsighted outlook of the mentors, professionals of the Industry. “There are many who made it possible for translating the ideas into action, the dreams into reality & local into global said Satya Brahma, Chairman, Organising Committee of 5^th Annual Pharmaceutical Leadership Summit & Awards 2012 ( www.asiapharmaleaders.com ), however, we decided to nominate the contemporary leaders with a strong visionary professionals who transformed Indian Healthcare Industry in many ways both to the Industry in general & their respective Company in particular  as “Pharma Professionals of The Decade 2012”.

Those who will don the mantle & will be felicitated at the glittering Award Ceremony on 21^st September in Mumbai at the Pharmaleaders’s ( www.pharmaleaders.co.in ) in association with Pharmexcil. India Brand Equity Foundation (IBEF) under the support from Ministry of Industry & Commerce, Government of India. are Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar & Microlab’s Ashok jain” added Satya Brahma in a News Release. Kewal Handa who will retire from the Board Members of Pfizer India & Wyeth will receive the coveted Title Transformational Pharma Leader of the Decade for his outstanding contribution to the Indian Healthcare Industry & changing the business landscape of Pfizer India’s presence in india & making it as the leading company in healthcare business.

5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 are running on a theme Brand India, Beyond Generics – Growth, Development & Diversifications.

His Excellency, Governor of Maharashtra, Shri Kateekal Sankaranarayanan in the presence of distinguished, dignitaries will give away the coveted Awards to the shingning stars of Indian Healthcare Sector such as Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar, & Microlab’s Ashok jain at the glittering Award Night in a suburban Hotel in Mumbai on  Friday, 21^st September 2012.

Aanjaneya Lifecare Eyes European Market, To Forge Collaborate Research with a German Pharma Major

Aanjaneya Lifecare Eyes European Market, To Forge Collaborate Research with a German Pharma Major

Middle East, Gulf & African Continents top on Agenda post Aanjaneya’s Robust Fiscal Growth Q1 Net  at 68 pc

‎Maharashtra, Mumbai, Monday, 13^th August 2012. In a sequel to Mumbai based Mid Cap Pharma Major Aanjaneya Lifecare’s grand acquisition in the beginning of this year in Feb which  was a first takeover by any Pharma Company. Aanjaneya Lifecare acquired Apex Drugs and Intermediates (ADI), a Hyderabad-based integrated active pharmaceutical ingredient (API) and intermediate company, for Rs.250 crore, including debt of Rs.185 crore and equity dilution of Rs.65 crore.

Sources close to pharmaledaers reveal that Aanjaneya Lifecare is close on partnering with a German Pharma major for collaborate Research, Crams & Co-Marketing Rights to sell the product range in the Middle East, Gulf & African Continents. In a Press Note to BSE, Aanjaneya Lifecare which announced its Q1 results informed the regulator that, The Board Members have approved the plans to set up offices in overseas markets such as Uganda, Tanzania, Dubai and Singapore. Aanjaneya had raised Rs 117 crore from its successful  IPO & has indicated that the funds will be used for Research, Crams & global expansion. The repeated attempts to reach aanjaneya Lifecare Spokesperson by Pharmaleaders yielded no results & sms sent to Dr Kannan Vishwanath, Vice-Chairman & MD was unanswered.

Pharmaleaders has learnt from its sources that Aanjaneya Lifecare, after successfully acquiring Apex Drugs which will will reduce the company's dependence on third parties for pricing and supply to a large extent & will open up doors for lifestyle segment was looking for a Research Partner to make its presence in NDDS, NCE & Crams in a big way, the proposesd collaboration will enhance the capabilities in a big way says Satya Brahma, Editor-In-Chief of Pharmaleaders, “Aanjaneya is on a road to its entering into the big league as Aanjaneya has a strong presence in API and formulation business and has bulk drug manufacturing facility at Mahad and a finished dosage forms unit near Pune. It is one of the largest contract manufacturers of codeine-based cough syrups in India and exclusively makes Codorex brand of Zydus Cadilla and Codilite tablets among others”. It may be noted here that the Shares of Aanjaneya Lifecare today closed at Rs 616.20 on BSE.

Aanjaneya Lifecare has been selected for Nomination for prestigious title “BSE Award for Best Return to Investors” organized by Pharmaleaders in association with Pharmexcil , Ministry of Commerce & Industry along with leading trade bodies at 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 in Mumbai on 21^st September.

Biocon Chief Dr. Kiran Majumdar Shaw & NMC Chief Dr B.R.Shetty Declared Global Indian Of The Year

Biocon Chief  Dr. Kiran Majumdar Shaw & NMC Chief Dr B.R.Shetty Declared Global Indian Of The Year

5^th Annual Pharmaceutical Leadership Awards 2012 will crown the iconic global leaders in Mumbai. Global Indian of the Year are  the highest title of recognition from Pharmaleaders.

Thursday, 9^th August 2012, Mumbai, Maharashtra:  When going gets tough, tough gets going, there are times when we have seen great iconic global figures have had their challenging days in an era of protectionist policy & license raj, yet unfazed & optimist of their dreams – to cross geographic boundaries, think global , embrace innovation in work & make it big yet remain simple in thinking, these are the signs of global icons & yes two such iconic personalities who have compelled the world to take note of their startling success are Dr Kiran Mazumdar Shaw of Biocon & Dr B R Shetty of NMC Healthcare. 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 ( www.asiapharmaleaders.com )  organised by Asia’s leading bi-monthly healthcare magazine Pharmaleaders (www.pharmaleaders.co.in ) will salute these two global icons in the commercial capital of India, Mumbai on 21^st September 2012 with the presence of who’s & who’s of healthcare industry, pharma academia, policy makers, brand icons & corporate biggies. Dr Kiran Mazumdar Shaw & Dr B .R. Shetty have been declared by the distinguished juries of the Pharmaleaders as “ Global Indian of the Year 2012” .

Announcing the names of Dr Kiran Shaw & Dr B R Shetty, Satya Brahma, Editor-In-Chief of Pharmaleaders Group said “ The Board Members of Pharmaleaders had no other names when it came to globe-throttling mission & making it big in global map purely on the strength of their self-belief, confidence & exuberance, Dr Kiran Shaw & Dr B R Shetty are the shining stars of the global healthcare Industry while one conquered in Biotechnology, the other experimented with quite a lot of different segments in healthcare, yet remained adamant on their objective, to become a global player”, added satya in a release to media. “It is indeed heartening to note that both of them cherished a dream quite contrary to other business leaders, their indomitable thinking, positive energy & meteoric rise to the global space has much to tell us that they have defied all odds & worked in a very hostile climate & earned the goodwill of becoming rarest of rare in business innovations said Satya. We are excited to give these two global icons.

 “It is a great honor for me to be nominated as the Global India of the Year 2012. I am deeply humbled and grateful to you for recognizing my achievements & I look forward to attending the Summit and Awards Ceremony” said Dr Shetty to Satya Brahma.

Dr. B.R.Shetty is the Founder, Managing Director & CEO of NMC Healthcare is a partner with Centurion Investments which is under the patronage of His Highness Sheikh Mansour bin Zayed Al Nahayan. Dr.B.R.Shetty was born in an agricultural family in Kaup, India. A graduate in Pharmacology, Dr.B.R.Shetty’s meteoric rise to the top is an awe inspiring testimony to what hardwork, passion and dedication can achieve. Over three decades after its inception, under Dr.B.R.Shetty’s dynamic leadership, NMC has flowered into a multi-activity conglomerate encompassing a diverse spectrum of businesses like Oil Field Supply and Oil Related Business, Healthcare, Financial Services & Money Remittances, Hospitality etc. Dr.Shetty is today considered a pioneer in healthcare and has been credited for being the first to offer a comprehensive range of healthcare services which cover the entire gamut of medical diagnosis and treatment under a single umbrella. Today, the NMC Healthcare family consists of six healthcare facilities in the UAE Dr. Shetty has acquired a hospital in Alexandria, Egypt which operates under the name of Alexandria New Medical Centre. Dr. B. R. Shetty’s clear vision and focus, indefatigable spirit and unflagging enthusiasm, has made him an active partner in the progress of the UAE. Dr. Shetty is committed to the cause of well being and health of its people, and his zeal is as strong as ever to spearhead this mission of change.

It takes originality and a strong will for a woman to first study brewing, and then to turn to a nascent industry when hurdles in the brewery business prove insurmountable. Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon, India's first biotechnology company. Biocon, today a billion-dollar company and Asia's largest biopharma concern, started in the garage of Mazumdar-Shaw's rented home in Bangalore, with seed capital of Rs10,000 (around Rs4 lakh today). When she set up what is now one of the top 20 biotechnology companies in the world, banks wanted her father. Her vision for the company has evolved from the goal of improving India's scientific record to the dream of "a made-in-India novel drug". When she talks about Biocon's plans to take insulins global and move from cancer care to cancer cure, her enthusiasm seems almost childlike.

5^th Annual Pharmaceutical Leadership Summit 2012 will also debate on crucial topics of the healthcare industry on Brand India theme by the veterans of the industry. The much awaited Event will be represented by many corporate tycoons & overseas healthcare experts.